Correspondances en Metabolismes Hormones Diabetes et Nutrition is a vital resource for researchers and practitioners in the fields of endocrinology, diabetes, and nutrition, published by EDIMARK SANTE in France. Established since 2009, this journal diligently focuses on the evolving relationship between metabolic processes and hormonal regulation, catering to the interdisciplinary nexus of food science and medicine. Although currently classified in the Q4 quartile for 2023 in its respective categories, the journal remains significant for its contributions to understanding metabolic disorders and nutritional impacts on health. With the growing global obesity epidemic and increasing diabetes prevalence, the journal aims to disseminate cutting-edge research, case studies, and reviews that will foster discussion and prompt innovation in treatment and dietary strategies. While it follows a traditional publishing model, its aim is to enhance accessibility to critical findings for a wide audience, from corporate researchers to clinical practitioners and students seeking in-depth knowledge in this crucial area.

Nature Reviews Endocrinology is a premier journal published by NATURE PORTFOLIO, providing comprehensive and critical reviews in the rapidly evolving field of endocrinology. Established to foster advanced understanding, it has become a vital resource for researchers, professionals, and students alike. With an impressive impact factor and a prominent ranking of Q1 in both Endocrinology and Endocrinology, Diabetes, and Metabolism categories for 2023, the journal is recognized for its high-quality research dissemination, evidenced by its rankings of #2 out of 244 in Medicine and #2 out of 128 in Biochemistry, Genetics, and Molecular Biology. Spanning the years from 2009 to 2024, it focuses on publishing cutting-edge information that shapes current scientific knowledge and clinical practices. The journal offers open access options, ensuring greater visibility and reach for its articles. Located in Germany, this journal remains at the forefront of endocrinology research, significantly contributing to the understanding of hormonal functions and their implications on health. Discover the latest advancements and insights by exploring Nature Reviews Endocrinology.

ANNALS OF NUTRITION AND METABOLISM is a prestigious academic journal dedicated to advancing the fields of nutrition and metabolism, published by KARGER, a renowned publisher known for its commitment to high-quality research dissemination. Founded in 1959, this journal has established itself as a crucial resource for researchers and practitioners alike, spanning an extensive range of topics that highlight the interplay between diet, health, and disease. Currently seated in Q2 categorically both in Medicine (Miscellaneous) and Nutrition and Dietetics, the journal ranks impressively within the Scopus metrics, showcasing its relevance and impact—positioned at the 80th percentile in Medicine and the 71st percentile in Nutrition. Though not open access, the journal ensures broad accessibility through various academic databases. By focusing on innovative research findings and clinical insights, the ANNALS OF NUTRITION AND METABOLISM aims to foster a deeper understanding of nutritional science, making it an indispensable platform for academics, healthcare professionals, and students alike to enhance their knowledge and contribute to ongoing discussions in this vital field.

The Journal of Obesity, published by HINDAWI LTD, stands at the forefront of research in the field of Endocrinology, Diabetes and Metabolism, providing a vital platform for the dissemination of knowledge and advancements in obesity research. With an impact factor that reflects its significance in the academic community—holding a prestigious Q2 ranking in its category—the journal has continuously evolved since its establishment as an Open Access publication in 2010, promoting unrestricted access to high-quality research. Operating from Egypt, the journal focuses on disseminating impactful studies that address the global epidemic of obesity, making a meaningful contribution to public health solutions. Researchers, professionals, and students in the related fields will find valuable insights and innovative findings within its pages, as the journal endeavors to bridge the gap between scientific research and practical application. As of 2023, it occupies a notable position, ranked #58 out of 244 in Scopus, showcasing its commitment to excellence and relevance in the rapidly evolving landscape of obesity research.

Archives of Endocrinology Metabolism is a distinguished open-access journal dedicated to advancing the field of endocrinology and metabolism. Published by SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIA, this journal has established itself as a vital platform for researchers, clinicians, and scholars since its inception in 2008. With an ISSN of 2359-3997 and E-ISSN of 2359-4292, it aims to disseminate high-quality research articles that explore the latest advancements in endocrinology, diabetes, and metabolism. As of 2023, it has achieved a commendable Q3 ranking in its field, demonstrating its relevancy and increasing visibility among peers. The journal's focus spans various sub-disciplines, including hormonal regulation, metabolic disorders, and innovative therapies, making it an essential resource for both emerging professionals and seasoned experts alike. With a rich repository of research from Brazil and beyond, Archives of Endocrinology Metabolism continuously seeks to contribute to the ongoing dialogue and collaboration within the global scientific community.

Lancet Diabetes & Endocrinology is a premier peer-reviewed journal, published by Elsevier Science Inc, dedicated to advancing the fields of endocrinology, diabetes, and metabolism. Established in 2013, this journal has quickly ascended to a position of notable prestige, reflected in its prestigious Q1 rank across various categories, including Endocrinology, Internal Medicine, and Diabetes & Metabolism. With an impressive impact factor and Scopus rankings placing it in the 99th percentile of its field, it serves as a vital resource for researchers, healthcare professionals, and students alike. The journal aims to disseminate high-quality research covering clinical and experimental aspects of metabolic and endocrine disorders, making it an indispensable tool for those looking to stay at the forefront of these rapidly evolving fields. With its focus on innovative depth and cutting-edge studies, Lancet Diabetes & Endocrinology continually fosters an international dialogue critical for advancements in diabetes and endocrinology.

Metabolic Syndrome and Related Disorders is an esteemed journal published by MARY ANN LIEBERT, INC, focusing on the multifaceted aspects of metabolic syndrome, including its interaction with chronic diseases such as diabetes, cardiovascular conditions, and obesity. Since its inception in 2003, this journal has established itself as a vital resource for researchers, healthcare professionals, and students dedicated to advancing knowledge in the fields of endocrinology, internal medicine, and metabolic disorders. With an impact factor reflective of its academic significance, Metabolic Syndrome and Related Disorders is recognized within the Q2 and Q3 quartiles in its respective categories, solidifying its reputation among scientific and clinical communities. Although it does not currently offer open access options, the journal remains committed to disseminating high-quality research and reviews that foster innovative solutions and improve patient outcomes. The journal's gradual convergence towards 2024 presents an exciting opportunity for continued exploration and dialogue about metabolic-related health challenges.

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, published by Springer, is a leading journal in the field of endocrinology, diabetes, and metabolism, with an impressive Q1 ranking in both categories as of 2023. With an ISSN of 1389-9155 and E-ISSN 1573-2606, this journal serves as a vital resource for researchers, clinicians, and students seeking comprehensive reviews that address the latest advancements and interdisciplinary approaches in the management of endocrine and metabolic disorders. Operating from the Netherlands, it features articles that are rigorously peer-reviewed and is notable for its significant impact factor reflected in its Scopus rankings, placing it in the top percentile of its categories. Although it does not currently offer open access, it provides critical insights applicable to both basic and clinical settings, making it indispensable for those dedicated to enhancing patient outcomes in endocrine health.

Diabetes Metabolic Syndrome and Obesity is a leading open-access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing research in the fields of diabetes, metabolic syndrome, and obesity. Since its inception in 2008, the journal has aimed to disseminate high-quality, peer-reviewed articles that contribute to our understanding of these prevalent health issues, with a special focus on clinical practices, therapeutic advancements, and epidemiological studies. Boasting a commendable Q2 ranking in both Internal Medicine and Pharmacology for 2023, the journal is placed among the top tier of its category, with a Scopus ranking of #44 out of 167 in Internal Medicine and #124 out of 313 in Pharmacology. This positions the journal in the 73rd and 60th percentiles, respectively, highlighting its significance in the academic community. Researchers and professionals are encouraged to utilize this journal as a valuable resource for access to groundbreaking studies and developments in the treatment and management of diabetes and related metabolic disorders, contributing to global health improvements.

Austrian Journal of Clinical Endocrinology and Metabolism, published by SPRINGER WIEN, serves as a pivotal platform for the dissemination of research in the field of endocrinology, diabetes, and metabolism. With its ISSN 1998-7773 and E-ISSN 1998-7781, this journal has been contributing valuable insights to the field since its inception in 2010. Although it currently holds a Q4 ranking in the category of Endocrinology, Diabetes and Metabolism, it is committed to improving its impact factor by showcasing high-quality, peer-reviewed articles that reflect contemporary challenges and innovations in clinical endocrinology. Located in Vienna, Austria, the journal aims to provide researchers, healthcare professionals, and students with access to the latest findings and clinical practices that advance understanding and treatment of endocrine disorders. Researchers interested in submitting their work will find a supportive environment that embraces both experimental and clinical approaches. The Austrian Journal of Clinical Endocrinology and Metabolism is poised to become a valuable resource for those dedicated to improving health outcomes in metabolic disorders.